Gastrointestinal

Gastrointestinal (GI) Cancer Treatment Trials

Protocol
Number

Title

ID

PV 10
LC 01
SLHN
2013 114

A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma Not Amenable to Resection or Transplant

Learn more.

NCT00986661
CTSU
CALGB
C80702

A Phase III Trial of 6 vs. 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer

Learn more.

NCT01150045
ECOG 7208

A Randomized Phase II Study of Irinotecan and Cetuximab With or Without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-Type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy

Learn more.

NCT01079780
Alliance A021202 SLHN 2013-80

Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754) Versus Placebo in Patients With Progressive Carcinoid Tumors

Learn more.

NCT01841736
 
Zaltrap
SLUHN 2013-84
Prospective international observational cohort non-comparative study describing the safety and effectiveness of ZALTRAP® administered in combination with FOLFIRI for the treatment of patients with metastatic colorectal cancer in current clinical practice: A Post-Authorisation Safety Study (PASS). N/A